Nearly a year after a nationwide outbreak of fungal meningitis erupted, new cases of the disease are still emerging, and efforts to tighten regulation of the type of pharmacy behind the outbreak are moving slowly.
Dangers from compounding pharmacies persist
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.